BOSTON SCIENTIFIC CORP — Director's Dealing 2019

Aug 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-08-02

Reporting Person: Pierce David A (EVP,Pres MedSurg)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-02	Common Stock	M	5000.0000	$6.2800	Acquired	29201.0000	Direct
2019-08-02	Common Stock	S	5000.0000	$42.6183	Disposed	24201.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-08-02	Stock Option (Right to Buy)	$6.2800	M	5000.0000	Disposed	2022-02-27	Common Stock (5000.0000)	Direct

Footnotes

F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $42.50 to $42.685, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.